Lam Research Corporation (LRCX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lam Research Corporation on October 2, 2024. The report details a material corporate action involving a stock split and amendments to the company's Restated Certificate of Incorporation.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure changes.
Material Changes
- Stock Split: A ten-for-one forward split of the Company's common stock was effected on October 2, 2024, at 5:00 p.m. Eastern Time.
- Authorized Shares: The number of authorized common shares increased proportionately from 400,000,000 to 4,000,000,000.
- Shareholder Rights: The split does not modify any rights or preferences of the common stock.
- Equity Adjustments: Proportionate adjustments were automatically made to outstanding equity awards, incentive plans, and exercise/conversion prices.
- Trading Details: Trading on the Nasdaq Global Select Market commenced on a split-adjusted basis on October 3, 2024, under the existing symbol "LRCX". The new CUSIP number is 512807306.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future outlook, or discuss specific risks and contingencies related to operations. It notes that stockholder approval was not required for the amendment under Section 242(d) of the General Corporation Law of the State of Delaware.
Key Facts for Investor Verification
- Verify the new CUSIP number (512807306) for post-split trading.
- Confirm that brokerage accounts reflect the 10-for-1 increase in share count and corresponding decrease in share price.
- Ensure that outstanding equity awards and option exercise prices have been adjusted proportionately.
- Note that the par value of the common stock remains unchanged at $0.001 per share.